コデイン

コデイン 化学構造式
76-57-3
CAS番号.
76-57-3
化学名:
コデイン
别名:
3-メトキシ-17-メチル-7,8-ジデヒドロ-4,5α-エポキシモルフィナン-6α-オール;3-メトキシ-17-メチル-4,5α-エポキシモルフィナ-7-エン-6α-オール;コジセプト;7,8-ジデヒドロ-4,5α-エポキシ-3-メトキシ-17-メチルモルフィナン-6α-オール;3-メトキシ-17-メチル-4,5α-エポキシ-7,8-ジデヒドロモルフィナン-6α-オール;(4aR,5S,7aR,8R,9cS)-3-メトキシ-12-メチル-4a,5,7a,8,9,9c-ヘキサヒドロ-8,9c-(イミノエタノ)フェナントロ[4,5-bcd]フラン-5-オール;(-)-コデイン;(5R,6S)-3-メトキシ-7,8-ジデヒドロ-4,5-エポキシ-17-メチルモルフィナン-6-オール;メチルモルフィン;コデイン;(1S,5R,13R,14S,17R)-10-メトキシ-4-メチル-12-オキサ-4-アザペンタシクロ[9.6.1.01,13.05,17.07,18]オクタデカ-7,9,11(18),15-テトラエン-14-オール
英語名:
CODEINE
英語别名:
CODEINE BASE;C06174;CODEINE;Coducept;Codicept;l-Codeine;Codeine (CRM);Methylmorphine;codeine solution;O3-Methylmorphine
CBNumber:
CB3407233
化学式:
C18H21NO3
分子量:
299.37
MOL File:
76-57-3.mol

コデイン 物理性質

融点 :
156-158?C
沸点 :
440.69°C (rough estimate)
比重(密度) :
1.3200
屈折率 :
1.5500 (estimate)
闪点 :
9℃
貯蔵温度 :
2-8°C
溶解性:
熱湯に溶け、エタノールに溶けやすい(96%)。
酸解離定数(Pka):
8.21(at 25℃)
外見 :
Solid
色:
White to Pale Brown
水溶解度 :
47.62g/L(25℃)
安定性::
安定していますが、光に敏感です。可燃性。強力な酸化剤、臭化物、ヨウ化物、重金属塩とは相容れない。
EPAの化学物質情報:
Codeine (76-57-3)
安全性情報
  • リスクと安全性に関する声明
  • 危険有害性情報のコード(GHS)
主な危険性  F,T
Rフレーズ  11-23/24/25-39/23/24/25
Sフレーズ  7-16-36/37-45
RIDADR  UN 1230 3/PG 2
WGK Germany  1
有毒物質データの 76-57-3(Hazardous Substances Data)
毒性 LD50 oral in rat: 427mg/kg
絵表示(GHS) GHS hazard pictogramsGHS hazard pictogramsGHS hazard pictograms
注意喚起語 危険
危険有害性情報
コード 危険有害性情報 危険有害性クラス 区分 注意喚起語 シンボル P コード
H225 引火性の高い液体および蒸気 引火性液体 2 危険 GHS hazard pictograms P210,P233, P240, P241, P242, P243,P280, P303+ P361+P353, P370+P378,P403+P235, P501
H370 臓器の障害 特定標的臓器有害性、単回暴露 1 危険 GHS hazard pictograms P260, P264, P270, P307+P311, P321,P405, P501
注意書き
P210 熱/火花/裸火/高温のもののような着火源から遠ざ けること。-禁煙。
P260 粉じん/煙/ガス/ミスト/蒸気/スプレーを吸入しないこ と。
P280 保護手袋/保護衣/保護眼鏡/保護面を着用するこ と。
P301+P310 飲み込んだ場合:直ちに医師に連絡すること。
P311 医師に連絡すること。

コデイン 化学特性,用途語,生産方法

解説

モルヒネ型アヘンアルカロイドの一種.アヘン中に0.7~2.5% 含まれるが,おもにモルヒネのメチル化により合成されるコデイン.

性質

通常,一水和物として無色の斜方晶となる.融点154~156 ℃.[α]D15"-136°(エタノール).水に微溶,エタノールに可溶.

用途

呼吸中枢に作用するので,リン酸塩を咳止め薬,鎮痛薬として用いる.

毒性

LD50 290 mg/kg(マウス,経口).

説明

Codein phosphate and hydrochloride caused contact dermatitis in a worker in the production of opium alkaloids. Codeine bitartrate caused contact dermatitis in a worker in the production of concentrated poppy straw. Codeine was a sensitizer in a laboratory worker at an opiate-manufacturing pharmaceutical company, also sensitive to the baine.

化学的特性

Codeine, also known as methylmorphine, C18H21NO3· H2O, is a colorless white crystalline substance, slightly soluble in water, soluble in alcohol and chloroform, effloresces slowly in dry air.

使用

Codeine is used in medicine for its narcoticanalgesic action. It is used as a sedative incough mixtures. Codeine occurs in opiumfrom 0.7% to 2.5%. It is prepared frommorphine by methylating the phenolic OHgroup of the morphine. It is also obtained byextraction of opium.

定義

codeine: An alkaloid C18H21NO3found in opium. It is structurally similarto morphine, from which it isproduced, and is used in the form ofthe sulphate or phosphate as apainkiller and cough medicine.Codeine is converted into morphinein the liver. It is used to some extentas a recreational drug. In the UK it isa class B drug but can be obtained incomposite over-the-counter preparationsin which it has a low concentrationand is combined with paracetamolor ibuprofen. See also opioids.

世界保健機関(WHO)

Codeine, which has antitussive, opioid analgesic and antidianhoeal activity, was first extracted from opium in 1832 and has since been widely used in medicine. The development of dependence and its potential for abuse resulted in the control af the substance under Schedule II of the 1961 Single Convention on Narcotic Drugs. Preparations containing codeine remain widely available and are included in the WHO Model List of Essential Drugs.(Reference: (WHTAC1) The Use of Essential Drugs, 2nd Report of the WHO Expert Committee, 722, , 1985)

生物学の機能

Like morphine, codeine is a naturally occurring opioid found in the poppy plant. Codeine is indicated for the treatment of mild to moderate pain and for its antitussive effects. It is widely used as an opioid antitussive because at antitussive doses it has few side effects and has excellent oral bioavailability. Codeine is metabolized in part to morphine, which is believed to account for its analgesic effect. It is one of the most commonly used opioids in combination with nonopioids for the relief of pain. The administration of 30 mg of codeine in combination with aspirin is equivalent in analgesic effect to the administration of 65 mg of codeine. The combination of the drugs has the advantage of reducing the amount of opioid required for pain relief and abolition of the pain via two distinct mechanisms, inhibition of prostanoid synthesis and opioid inhibition of nociceptive transmission. When given alone, orally administered codeine has about one-tenth to one-fifth the potency of morphine for the relief of pain. In addition, IV codeine has a greater tendency to release histamine and produce vasodilation and hypotension than does morphine. Thus, the use of IV codeine is rare. Codeine is rarely addictive and produces little euphoria.

一般的な説明

Codeine is an alkaloid that occurs naturally in opium, butthe amount present is usually too small to be of commercialimportance. Consequently, most commercial codeine is preparedfrom morphine by methylating the phenolic OHgroup. It occurs as levorotatory, colorless, efflorescent crystals,or as a white crystalline powder. It is light sensitive.Codeine is a monoacidic base and readily forms salts withacids, with the most important being the sulfate and thephosphate. The acetate and methylbromide derivatives havebeen used to a limited extent in cough preparations.The general pharmacological action of codeine is similarto that of morphine, but it does not possess the sameanalgesic potency.

空気と水の反応

CODEINE is light sensitive and sensitive to prolonged exposure to air. Insoluble in water.

反応プロフィール

CODEINE is incompatible with bromides, iodides and salts of heavy metals. . CODEINE is an amine. Amines are chemical bases. They neutralize acids to form salts plus water. These acid-base reactions are exothermic. The amount of heat that is evolved per mole of amine in a neutralization is largely independent of the strength of the amine as a base. Amines may be incompatible with isocyanates, halogenated organics, peroxides, phenols (acidic), epoxides, anhydrides, and acid halides. Flammable gaseous hydrogen is generated by amines in combination with strong reducing agents, such as hydrides.

危険性

Habit-forming narcotic, sale legally restricted.

健康ハザード

The toxic effects due to codeine are similarbut less toxic than those of morphineand other opium alkaloids. An overdosecan cause respiratory failure. It is a weakdepressant of the central nervous system.It also exhibits stimulant action. Toxicsymptoms from high dosages may includedrowsiness, sleep, tremors, excitement, andhallucinations. It may also produce gastricpains and constipation. An oral LD50 value in rats is 427 mg/kg. The habit-forming effectsof codeine are lower than those associatedwith morphine.
Nagamatsu and coworkers (1985) havereported in vitro formation of codeinonefrom codeine by rat or guinea pig liverhomogenate. Codeinone may be a metabolicintermediate in the presence of nicotinamideadenine dinucleotide (NAD). Its acute toxicityin mice was determined to be 30 timeshigher than that of codeine.

火災危険

CODEINE is combustible.

接触アレルゲン

Codeine has been reported as an occupational sensitizer in workers in the production of opium alkaloids. Codeine has been responsible for fixed drug eruptions or generalized dermatitis. Cross-sensitivity is expected to morphine.

薬理学

Codeine is a constituent of opium. Up to 10% of a dose of codeine is metabolised by the hepatic microsomal enzyme CYP2D6 to morphine, which contributes significantly to its analgesic effect. The rest is metabolised in the liver to norcodeine and then conjugated to produce glucuronide conjugates of codeine, norcodeine and morphine. Codeine is considerably less potent than morphine. A round 8% of Western Europeans are deficient in the CYP2D6 enzyme and may not experience adequate analgesia with codeine. S imilarly, with super-metabolisers, there may be problems with opioid toxicity; particular care is needed in the breastfeeding mother as morphine is transferred in milk. Codeine can cause significant histamine release, and intravenous administration should be avoided. It has marked antitussive effects and also causes significant constipation. It is often combined with paracetamol.

純化方法

Codeine crystallises from water or aqueous EtOH. Dry it at 80o. Evaporation of a CHCl3 extract gives a colourless glass which crystallises on scratching. It crystallises from H2O as the monohydrate, m 157-158.5o, and has [] D -136o (c 2.8, EtOH). The hydrobromide crystallises in needles from H2O, and effervesces at 151-160o, solidifies and remelts with extensive decomposition at 273-278o. It sublimes at 100o/0.03mm. [Gates J Am Chem Soc 75 4340 1953, Dauben et al. J Org Chem 44 1567 1979, Beilstein 27 II 136, 27 III/IV 2228.]

コデイン 上流と下流の製品情報

原材料

準備製品

76-57-3(コデイン)キーワード:


  • 76-57-3
  • CODEINE HYDROCHLORIDE-HYDRATE
  • CODEINE
  • MORPHINAN-6-OL,7,8-DIDEHYDRO-4,5-EPOXY-3-METHOXY-17-METHYL-, (5A,6A)-
  • 7,8-Didehydro-4,5alpha-epoxy-3-methoxy-17-methyl morphinan-6alpha-ol
  • 7,8-didehydro-4,5-alpha-epoxy-3-methoxy-17-methyl-morphinan-6-alpha-o
  • 7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methyl-morphinan-6alpha-o
  • 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-,(5alpha,6alpha)-morphinan-6-o
  • 7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol
  • Codeine [anhydrous]
  • Codicept
  • Coducept
  • l-Codeine
  • Methylmorphine
  • Morphinan-6alpha-ol, 7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methyl-
  • Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-
  • Morphine monomethyl ether
  • Morphine, 3-methyl ether
  • morphine-3-methylester
  • morphine-3-methylether
  • Methanol ( Test Codeine, 1.0 mg/mL)
  • morphine3-methylether
  • morphinemonomethylether
  • Norcodeine, N-methyl-
  • norcodeine,n-methyl
  • norcodine,n-methyl
  • O3-Methylmorphine
  • Codeine Base [D.D]
  • codeine methanol solution
  • codeine--dea schedule ii item
  • codeine solution
  • 3-メトキシ-17-メチル-7,8-ジデヒドロ-4,5α-エポキシモルフィナン-6α-オール
  • 3-メトキシ-17-メチル-4,5α-エポキシモルフィナ-7-エン-6α-オール
  • コジセプト
  • 7,8-ジデヒドロ-4,5α-エポキシ-3-メトキシ-17-メチルモルフィナン-6α-オール
  • 3-メトキシ-17-メチル-4,5α-エポキシ-7,8-ジデヒドロモルフィナン-6α-オール
  • (4aR,5S,7aR,8R,9cS)-3-メトキシ-12-メチル-4a,5,7a,8,9,9c-ヘキサヒドロ-8,9c-(イミノエタノ)フェナントロ[4,5-bcd]フラン-5-オール
  • (-)-コデイン
  • (5R,6S)-3-メトキシ-7,8-ジデヒドロ-4,5-エポキシ-17-メチルモルフィナン-6-オール
  • メチルモルフィン
  • コデイン
  • (1S,5R,13R,14S,17R)-10-メトキシ-4-メチル-12-オキサ-4-アザペンタシクロ[9.6.1.01,13.05,17.07,18]オクタデカ-7,9,11(18),15-テトラエン-14-オール
  • 麻薬性鎮痛薬
  • 鎮咳薬
  • 制瀉薬
Copyright 2017 © ChemicalBook. All rights reserved